ClinicalTrials.gg
Not yet recruitingNCT07631416Updated Jun 8, 2026

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia

A Phase 4 interventional study of 0.25% bupivacaine in Post op Pain in Hip Surgeries, sponsored by Sohag University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-08.

Sponsored by Sohag University · Phase 4, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 146 studies testing bupivacaine in Pain — 19 open to participants now, 19 under way, 3 of them phase 3. Bupivacaine · Pain.

Planned enrollment
10th of 146
200 · median 63
Started
2026
with 5 others
Phase 4
55 of 146
6 open now
Primary completion
2026-11
later than 9 of 18 live
Registered
142nd of 146
by date
Lead sponsor
3 of 146
Sohag University

Among the 146 studies testing bupivacaine in Pain, this one is the 10th largest by planned enrollment, is one of 6 that started in 2026, is one of 55 in phase 4, reaches primary completion later than 9 of the 18 other live ones, and was the 142nd registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

19 of the 146 studies testing bupivacaine in Pain are open now, in 5 countries. Recruiting first, the newest first:

13 more — sign in →

By country, each count listing its studies:

All 19 open studies →

About bupivacaine

Bupivacaine: first FDA approval 1972 (MARCAINE HYDROCHLORIDE PRESERVATIVE FREE), first EMA approval 2020. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 146 studies testing bupivacaine in Pain, or all of them as a file.
02

Study summary

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.

Read the detailed description

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.

Primary outcome:

  • Follow up postoprative pain.

Secondary outcome:

  • Requirment of analgesic drugs either (opoid or non opoid) postoprative.
03

Conditions studied

  • Post op Pain in Hip Surgeries

Browse trials for

Keywords

  • post op pain in hip surgeries
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Age between ≥ 18 years

      • Both sexes.
      • (ASA) Physical Status I-III
      • Undergoing elective unilateral hip surgeries under spinal anesthesia
      • Patients with (BMI) \< 35 kg/m²

Exclusion criteria

Exclusion Criteria:

    • Patient refusal

      • Known allergy to local anesthetics
      • Infection at the site of block
      • Coagulopathy or bleeding disorders
      • Cognitive impairment affecting pain assessment
      • Chronic opioid use
      • Neuromuscular disorders as patients with stroke.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    group A lumber electrospine plane block

    20ml of 0.25% bupivacaine will be injected into the interfascial plane between the erector spinae muscle and L5 transverse process.

    Drug: 0.25% bupivacaine

  • Active comparator
    group B fascia iliaca plane block

    a total of 20 mL of 0.25% bupivacaine will be slowly injected in fascia iliaca

    Drug: 0.25% bupivacaine

Interventions

  • DrugBupivacaineStudies of BupivacaineBupivacaine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia

    Also known as: 0.25% isobaric bupivacaine

06

What researchers measure

Primary outcomes

  1. follow up postoperative pain by Visual Analogue Scale (VAS)score

    follow up postoperative pain every 2hours

    Time frame: follow up postoperative pain in 24 hours

Secondary outcomes

  1. Requirment of analgesic drugs either (opoid or non opoid) postoprative by Viscual Analogue Scale (VAS) Score

    Requirment of analgesic drugs either (opoid or non opoid) postoprative.every 2hours

    Time frame: Requirment of analgesic drugs either (opoid or non opoid) postoprative. in 24hours

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2026; primary completion for Nov 2026, 6 months later.

Of 280 non-industry phase 4 interventional studies under Pain, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 35. This study's planned 6 months is below that.

Counting every sponsor, half of 295 studies reached it within 18 months; a quarter within 8 and three quarters within 33.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 9, 2026
First posted
Jun 8, 2026
StartEst.
May 20, 2026
Primary completionEst.
Nov 28, 2026
CompletionEst.
Nov 28, 2026
Last update
Jun 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07631416
Lead sponsor
Sohag University
Responsible party
Hadeer Ali Darder (Resident at Anesthesia department, Sohag University) — Principal investigator
First posted
Jun 8, 2026
Start date
May 20, 2026 (estimated)
Primary completion
Nov 28, 2026 (estimated)
Completion
Nov 28, 2026 (estimated)
Last update
Jun 8, 2026

Study contacts

hadeer ali, resident
Contact
doradoctora46@gmail.com
01115813875 ext. 01115813875

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Bupivacaine

Start the discussion